DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,239,658 | -1.2% | 77,548 | -4.4% | 0.56% | -0.2% |
| Q2 2023 | $19,476,000 | -6.2% | 81,150 | -1.5% | 0.56% | -12.3% |
| Q1 2023 | $20,761,290 | +94458.6% | 82,373 | -0.4% | 0.64% | -7.8% |
| Q4 2022 | $21,956 | -99.9% | 82,719 | -52.1% | 0.69% | -10.4% |
| Q3 2022 | $22,322,300 | -0.9% | 172,672 | +94.3% | 0.77% | +1.2% |
| Q2 2022 | $22,528,000 | -6.9% | 88,863 | +7.7% | 0.76% | -15.0% |
| Q1 2022 | $24,194,000 | -10.1% | 82,479 | +0.8% | 0.89% | -7.0% |
| Q4 2021 | $26,917,000 | +3.4% | 81,812 | -4.3% | 0.96% | -2.2% |
| Q3 2021 | $26,020,000 | +4.4% | 85,466 | -8.0% | 0.98% | +5.8% |
| Q2 2021 | $24,922,000 | +13.0% | 92,865 | -5.2% | 0.93% | +6.2% |
| Q1 2021 | $22,050,000 | -0.5% | 97,964 | -1.8% | 0.88% | -6.2% |
| Q4 2020 | $22,162,000 | +1.6% | 99,766 | -1.5% | 0.93% | -11.3% |
| Q3 2020 | $21,807,000 | +12.8% | 101,270 | -7.3% | 1.05% | +6.4% |
| Q2 2020 | $19,326,000 | +26.4% | 109,294 | -1.1% | 0.99% | +5.2% |
| Q1 2020 | $15,294,000 | -10.1% | 110,498 | -0.3% | 0.94% | +12.7% |
| Q4 2019 | $17,010,000 | -1.2% | 110,830 | -7.1% | 0.83% | -3.9% |
| Q3 2019 | $17,222,000 | +1.2% | 119,242 | +0.1% | 0.87% | +0.2% |
| Q2 2019 | $17,019,000 | +7.3% | 119,084 | -0.9% | 0.87% | +4.5% |
| Q1 2019 | $15,866,000 | +24.1% | 120,184 | -3.1% | 0.83% | +17.1% |
| Q4 2018 | $12,789,000 | -6.2% | 124,024 | -1.2% | 0.71% | +5.2% |
| Q3 2018 | $13,641,000 | +6.2% | 125,542 | -3.5% | 0.67% | +1.5% |
| Q2 2018 | $12,844,000 | -3.3% | 130,159 | -4.0% | 0.66% | -5.3% |
| Q1 2018 | $13,279,000 | -1.7% | 135,624 | -6.8% | 0.70% | +0.3% |
| Q4 2017 | $13,511,000 | +3.3% | 145,561 | -4.6% | 0.70% | -1.8% |
| Q3 2017 | $13,081,000 | -5.6% | 152,505 | -7.1% | 0.71% | -6.4% |
| Q2 2017 | $13,859,000 | -8.4% | 164,226 | -7.2% | 0.76% | -8.5% |
| Q1 2017 | $15,134,000 | -0.3% | 176,939 | -9.2% | 0.83% | -4.6% |
| Q4 2016 | $15,175,000 | -17.7% | 194,953 | -17.2% | 0.87% | -17.4% |
| Q3 2016 | $18,448,000 | -41.3% | 235,338 | -24.4% | 1.06% | -40.7% |
| Q2 2016 | $31,420,000 | +4.5% | 311,093 | -1.9% | 1.78% | +0.5% |
| Q1 2016 | $30,073,000 | +1.1% | 317,028 | -1.0% | 1.77% | +0.6% |
| Q4 2015 | $29,752,000 | +25.1% | 320,331 | +14.8% | 1.76% | +22.1% |
| Q3 2015 | $23,777,000 | -0.9% | 279,033 | -0.4% | 1.44% | +7.0% |
| Q2 2015 | $23,988,000 | +0.1% | 280,267 | -0.7% | 1.35% | +3.0% |
| Q1 2015 | $23,971,000 | -2.5% | 282,341 | -1.6% | 1.31% | -16.5% |
| Q4 2014 | $24,584,000 | +10.5% | 286,836 | -2.0% | 1.57% | +8.1% |
| Q3 2014 | $22,245,000 | -0.8% | 292,774 | +2.8% | 1.45% | -14.2% |
| Q2 2014 | $22,418,000 | +2.7% | 284,744 | -2.2% | 1.69% | -15.6% |
| Q1 2014 | $21,835,000 | -13.7% | 291,126 | -11.2% | 2.00% | -13.4% |
| Q4 2013 | $25,303,000 | +11.0% | 327,766 | -0.3% | 2.31% | -1.4% |
| Q3 2013 | $22,796,000 | +7.9% | 328,854 | -1.4% | 2.34% | +5.2% |
| Q2 2013 | $21,121,000 | – | 333,664 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |